Your browser doesn't support javascript.
loading
European polygenic risk score for prediction of breast cancer shows similar performance in Asian women.
Ho, Weang-Kee; Tan, Min-Min; Mavaddat, Nasim; Tai, Mei-Chee; Mariapun, Shivaani; Li, Jingmei; Ho, Peh-Joo; Dennis, Joe; Tyrer, Jonathan P; Bolla, Manjeet K; Michailidou, Kyriaki; Wang, Qin; Kang, Daehee; Choi, Ji-Yeob; Jamaris, Suniza; Shu, Xiao-Ou; Yoon, Sook-Yee; Park, Sue K; Kim, Sung-Won; Shen, Chen-Yang; Yu, Jyh-Cherng; Tan, Ern Yu; Chan, Patrick Mun Yew; Muir, Kenneth; Lophatananon, Artitaya; Wu, Anna H; Stram, Daniel O; Matsuo, Keitaro; Ito, Hidemi; Chan, Ching Wan; Ngeow, Joanne; Yong, Wei Sean; Lim, Swee Ho; Lim, Geok Hoon; Kwong, Ava; Chan, Tsun L; Tan, Su Ming; Seah, Jaime; John, Esther M; Kurian, Allison W; Koh, Woon-Puay; Khor, Chiea Chuen; Iwasaki, Motoki; Yamaji, Taiki; Tan, Kiak Mien Veronique; Tan, Kiat Tee Benita; Spinelli, John J; Aronson, Kristan J; Hasan, Siti Norhidayu; Rahmat, Kartini.
Afiliación
  • Ho WK; School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, Semenyih, 43500, Selangor, Malaysia. weangkee.ho@nottingham.edu.my.
  • Tan MM; Cancer Research Malaysia, 1 Jalan SS12/1A, Subang Jaya, 47500, Selangor, Malaysia. weangkee.ho@nottingham.edu.my.
  • Mavaddat N; School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, Semenyih, 43500, Selangor, Malaysia.
  • Tai MC; Cancer Research Malaysia, 1 Jalan SS12/1A, Subang Jaya, 47500, Selangor, Malaysia.
  • Mariapun S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, Cambridge, UK.
  • Li J; Cancer Research Malaysia, 1 Jalan SS12/1A, Subang Jaya, 47500, Selangor, Malaysia.
  • Ho PJ; School of Mathematical Sciences, Faculty of Science and Engineering, University of Nottingham Malaysia, Jalan Broga, Semenyih, 43500, Selangor, Malaysia.
  • Dennis J; Cancer Research Malaysia, 1 Jalan SS12/1A, Subang Jaya, 47500, Selangor, Malaysia.
  • Tyrer JP; Human Genetics, Genome Institute of Singapore, 60 Biopolis St, 138672, Singapore, Singapore.
  • Bolla MK; Department of Surgery, National University Hospital and NUHS, 1E Kent Ridge Road, 119228, Singapore, Singapore.
  • Michailidou K; Human Genetics, Genome Institute of Singapore, 60 Biopolis St, 138672, Singapore, Singapore.
  • Wang Q; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, Cambridge, UK.
  • Kang D; Strangeways Research Laboratory, University of Cambridge, 2 Worts' Causeway, Cambridge, UK.
  • Choi JY; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, Cambridge, UK.
  • Jamaris S; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, Cambridge, UK.
  • Shu XO; Biostatistics Unit, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, 2371, Ayios, Dometios, Cyprus.
  • Yoon SY; Cyprus School of Molecular Medicine, The Cyprus Institute of Neurology & Genetics, 6 Iroon Avenue, 2371, Ayios, Dometios, Cyprus.
  • Park SK; Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, CB1 8RN, Cambridge, UK.
  • Kim SW; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, 03080, Seoul, Korea.
  • Shen CY; Department of Biomedical Sciences, Seoul National University Graduate School, 103 Daehak-Ro, Jongno-Gu, 03080, Seoul, Korea.
  • Yu JC; Cancer Research Institute, Seoul National University, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Tan EY; Department of Biomedical Sciences, Seoul National University Graduate School, 103 Daehak-Ro, Jongno-Gu, 03080, Seoul, Korea.
  • Chan PMY; Cancer Research Institute, Seoul National University, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Muir K; Department of Surgery, Faculty of Medicine, University of Malaya, Jalan Universiti, 50630, Kuala Lumpur, Malaysia.
  • Lophatananon A; Division of Epidemiology, Department of Medicine, Vanderbilt Epidemiology Center, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 1161 21st Ave S # D3300, Nashville, TN, 37232, USA.
  • Wu AH; Cancer Research Malaysia, 1 Jalan SS12/1A, Subang Jaya, 47500, Selangor, Malaysia.
  • Stram DO; Department of Preventive Medicine, Seoul National University College of Medicine, 103 Daehak-Ro, Jongno-Gu, 03080, Seoul, Korea.
  • Matsuo K; Department of Biomedical Sciences, Seoul National University Graduate School, 103 Daehak-Ro, Jongno-Gu, 03080, Seoul, Korea.
  • Ito H; Cancer Research Institute, Seoul National University, 103 Daehak-Ro, Jongno-Gu, Seoul, 03080, Korea.
  • Chan CW; Department of Surgery, Daerim Saint Mary's Hospital, 657 Siheung-Daero, Daerim-Dong, Yeongdeungpo-Gu, 07442, Seoul, Korea.
  • Ngeow J; Institute of Biomedical Sciences, Academia Sinica, 115128, Section 2, Academia Road, Taipei, Taiwan.
  • Yong WS; School of Public Health, China Medical University, Taichung, Taiwan.
  • Lim SH; Department of Surgery, Tri-Service General Hospital, Taipei, 114, Taiwan.
  • Lim GH; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
  • Kwong A; Department of General Surgery, Tan Tock Seng Hospital, Singapore, 308433, Singapore.
  • Chan TL; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, The University of Manchester, Oxford Road, M13 9PL, Manchester, UK.
  • Tan SM; Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, The University of Manchester, Oxford Road, M13 9PL, Manchester, UK.
  • Seah J; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, 90033, CA, USA.
  • John EM; Department of Preventive Medicine, Keck School of Medicine, University of Southern California, 1975 Zonal Ave, Los Angeles, 90033, CA, USA.
  • Kurian AW; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-Ku, 464-8681, Nagoya, Japan.
  • Koh WP; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, 466-8550, Nagoya, Japan.
  • Khor CC; Division of Cancer Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-Ku, 464-8681, Nagoya, Japan.
  • Iwasaki M; Division of Cancer Epidemiology, Nagoya University Graduate School of Medicine, 65 Tsurumai-Cho, Showa-Ku, 466-8550, Nagoya, Japan.
  • Yamaji T; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore, Singapore.
  • Tan KMV; National University Hospital, National University Health System, Singapore, Singapore.
  • Tan KTB; Division of Medical Oncology, National Cancer Centre Singapore, 11 Hospital Drive, 169610, Singapore, Singapore.
  • Spinelli JJ; Oncology Academic Clinical Program, Duke-NUS Graduate Medical School, 8 College Road, 169857, Singapore, Singapore.
  • Aronson KJ; Division of Surgical Oncology, National Cancer Centre, Singapore, Singapore.
  • Hasan SN; Breast Department, KK Women's and Children's Hospital, Singapore, 100 Bukit Timah Road, 229899, Singapore.
  • Rahmat K; Breast Department, KK Women's and Children's Hospital, Singapore, 100 Bukit Timah Road, 229899, Singapore.
Nat Commun ; 11(1): 3833, 2020 07 31.
Article en En | MEDLINE | ID: mdl-32737321
ABSTRACT
Polygenic risk scores (PRS) have been shown to predict breast cancer risk in European women, but their utility in Asian women is unclear. Here we evaluate the best performing PRSs for European-ancestry women using data from 17,262 breast cancer cases and 17,695 controls of Asian ancestry from 13 case-control studies, and 10,255 Chinese women from a prospective cohort (413 incident breast cancers). Compared to women in the middle quintile of the risk distribution, women in the highest 1% of PRS distribution have a ~2.7-fold risk and women in the lowest 1% of PRS distribution has ~0.4-fold risk of developing breast cancer. There is no evidence of heterogeneity in PRS performance in Chinese, Malay and Indian women. A PRS developed for European-ancestry women is also predictive of breast cancer risk in Asian women and can help in developing risk-stratified screening programmes in Asia.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Herencia Multifactorial / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Herencia Multifactorial / Polimorfismo de Nucleótido Simple Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Asia / Europa Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2020 Tipo del documento: Article País de afiliación: Malasia Pais de publicación: ENGLAND / ESCOCIA / GB / GREAT BRITAIN / INGLATERRA / REINO UNIDO / SCOTLAND / UK / UNITED KINGDOM